Research Group
Cancer Biomarkers
Sponsor
M.D. Anderson Cancer Center
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00539162
The goal of this clinical research study is to evaluate a method involving a blood test, called CA-125, that may be helpful in the early detection of ovarian cancer in women who are at low risk.
Intervention
Questionnaire
Condition
Ovarian Cancer
Investigators
Karen H. Lu, MD, Brian Slomovitz, MD, Georgia McCann, MD, Richard Moore, MD, Laura Holman, MD, Marian Williams-Brown, MD